213 related articles for article (PubMed ID: 15487853)
1. [Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Diehm C; Lawall H; Huber R
Med Klin (Munich); 2004 Aug; 99 Suppl 1():14-20. PubMed ID: 15487853
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of peripheral arterial disease.
Diehm C; Kareem S; Lawall H
Vasa; 2004 Nov; 33(4):183-9. PubMed ID: 15623192
[TBL] [Abstract][Full Text] [Related]
3. [Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease].
MMW Fortschr Med; 2004; 146 Suppl 1():6-7. PubMed ID: 15493409
[No Abstract] [Full Text] [Related]
4. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy in peripheral arterial disease.
Aronow WS
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):265-7. PubMed ID: 15379619
[TBL] [Abstract][Full Text] [Related]
6. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
Guirgis M; Thompson P; Jansen S
J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
[TBL] [Abstract][Full Text] [Related]
7. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
8. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Hiatt WR
J Intern Med; 2002 Mar; 251(3):193-206. PubMed ID: 11886478
[TBL] [Abstract][Full Text] [Related]
9. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
Poredos P; Jezovnik MK
Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
[TBL] [Abstract][Full Text] [Related]
10. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs in peripheral arterial disease.
Tulsyan N; Ouriel K; Kashyap VS
Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
[TBL] [Abstract][Full Text] [Related]
12. Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events.
Caro JJ; Migliaccio-Walle K
Am J Med; 1999 Dec; 107(6):568-72. PubMed ID: 10625025
[TBL] [Abstract][Full Text] [Related]
13. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
Füessl HS
MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
[No Abstract] [Full Text] [Related]
14. [Platelet inhibition in clinical practice].
Meyer S
Ther Umsch; 2012 Nov; 69(11):631-3. PubMed ID: 23117665
[TBL] [Abstract][Full Text] [Related]
15. [Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study].
Haldemann R; Lüscher TF; Szucs TD
Praxis (Bern 1994); 2001 Mar; 90(13):539-45. PubMed ID: 11550619
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the use of platelet aggregation inhibitors in PAD patients.
Agnelli G
Vasc Med; 2001; 6(3 Suppl):13-5. PubMed ID: 11789961
[TBL] [Abstract][Full Text] [Related]
17. [The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].
Drouet L; Bal dit Sollier C; Henry P
Drugs; 2010 Nov; 70 Suppl 1():9-14. PubMed ID: 20977287
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Hummel T; Meves SH; Rüdiger K; Mügge A; Mumme A; Burkert B; Mühlberger D; Neubauer H
Chirurg; 2016 May; 87(5):446-54. PubMed ID: 27138269
[TBL] [Abstract][Full Text] [Related]
20. Management of peripheral arterial disease.
Hilleman DE
Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S21-7. PubMed ID: 9784799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
